SUN PHARMACEUTICAL INDUSTRIES LIMITED (NSE : SUNPHARMA) Q4 FY23 Earnings Concall dated May. 26, 2023. Corporate Participants: Abhishek Sharma -- Head of
Search Results for: SUNPHARMA
Sun Pharmaceutical Industries Limited (SUNPHARMA) Q3 FY23 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY23 Earnings Concall dated Jan. 31, 2023 Corporate Participants: Abhishek Sharma -- Head of Investor Relations and
Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY23 Earnings Concall dated Nov. 01, 2022 Corporate Participants: Nimish Desai -- Investor Relations Dilip S.
Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q1 FY23 Earnings Concall Transcript
Sun Pharmaceutical Industries Ltd (NSE:SUNPHARMA) Q1 FY23 Earnings Concall dated Jul. 29, 2022 Corporate Participants: Nimish Desai -- Investor Relations Dilip Shanghvi
Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q3 FY22 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE: SUNPHARMA) Q3 FY22 Earnings Concall dated Jan. 31, 2022 Corporate Participants: Nimish Desai -- Head of Investor Relations Dilip
Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY22 Earnings Concall Transcript
Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA) Q2 FY22 Earnings Call dated Nov. 02, 2021 Corporate Participants: Nimish Desai -- Head-Investor Relations Dilip Shanghvi --
Sun Pharmaceutical Q3FY23; 3% Growth in Profits
Sun Pharmaceutical Industries Limited’s revenue in Q3FY23 rose 14% to ₹ 112,410 millions. Consolidated Profit After Tax came at ₹ 21,808 millions
Sun Pharmaceutical Industries Limited Q2 FY23 Earnings Conference Call Insights
Key highlights from Sun Pharmaceutical Industries Limited (SUNPHARMA) Q2 FY23 Earnings Concall Q&A Highlights: [00:16:46] Tushar Manudhane of Motilal Oswal asked about
Sun Pharmaceutical Industries Ltd Q1 FY23 Earnings Conference Call Insights
Key highlights from Sun Pharmaceutical Industries Ltd (SUNPHARMA) Q1 FY23 Earnings Concall Management Update: SUNPHARMA recorded the highest ever quarterly revenue in
Infographic: Key highlights from Sun Pharma Q3 2022 earnings results
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its third-quarter 2022 earnings results today. The company reported consolidated revenue of ₹10,295 crores with a growth of
Key highlights from Sun Pharma Q2 2022 earnings results
Sun Pharmaceutical Industries (NSE: SUNPHARMA) reported its second-quarter 2022 earnings results today. The company reported consolidated revenue of ₹98.4 billion with a